• Corporate Profile
• Stock Information
• Shareholder Information
• SEC Filings
• Annual Reports
• Investor News
• Board of Directors
• Board Committee Charters
• Code of Ethics
• Contact Investor Relations

• Akorn, Inc. Announces First Quarter 2012 Earenings Release AND Conference Call Information... Read More
• Akorn Announces the Approval and Launch of Generic Vancocin®... Read More
• See All Investor News

Home  |  Contact Us  |  Legal & Privacy  |  Site Map

A Niche Generic Pharmaceutical Company

©Akorn, Incorporated  |  Lake Forest, Illinois, USA